BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Candelaria RP, Adrada BE, Hess K, et al. (2020) Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. European Journal of Radiology. 130: 109170 |
| Liu Y, Fan J, Xu T, et al. (2020) Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation. Science Advances. 6: eaaz6162 |
| Wang Y, Janku F, Piha-Paul S, et al. (2020) Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Scientific Reports. 10: 3080 |
| Abuhadra N, Hess K, Litton J, et al. (2020) Abstract P1-10-20: Serial TILs: Evaluating the role of mid-treatment tumor infiltrating lymphocytes (TIL) in predicting pathologic complete response (pCR) in early-stage triple negative breast cancer (TNBC) Cancer Research |
| Maymani H, Hess K, Groisberg R, et al. (2019) Corrigendum to "Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials" [Lung Cancer 120 (June) (2018) 137-141]. Lung Cancer (Amsterdam, Netherlands) |
| Kurnit KC, Meric-Bernstam F, Hess K, et al. (2019) Abstract CT020: Phase I dose escalation of olaparib (PARP inhibitor) and selumetinib (MEK Inhibitor) combination in solid tumors with Ras pathway alterations Cancer Research. 79 |
| Hegde A, Huang L, Liu S, et al. (2019) Abstract 4997: Responsiveness to immune checkpoint inhibitors in RET dependent cancers Cancer Research. 79: 4997-4997 |
| Sen S, Pestana RC, Hess K, et al. (2019) Abstract 3997: Outcomes of geriatric sarcoma patients enrolled in phase 1 clinical trials Cancer Research. 79: 3997-3997 |
| Crespo J, Sahil S, Ravenberg E, et al. (2019) Abstract 1409: Characterization of the LAR subtype triple negative breast cancer population Cancer Research. 79: 1409-1409 |
| Majd N, Mastall M, Hess K, et al. (2019) RARE-47. CHARACTERIZATION OF ADULT MEDULLOBLASTOMA; A RETROSPECTIVE REVIEW OF 200 PATIENTS AT MD ANDERSON CANCER CENTER Neuro-Oncology. 21: vi231-vi232 |